Penumbra, Inc.

NYSE:PEN Stock Report

Market Cap: US$9.1b

Penumbra Balance Sheet Health

Financial Health criteria checks 6/6

Penumbra has a total shareholder equity of $1.1B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.5B and $374.8M respectively. Penumbra's EBIT is $78.5M making its interest coverage ratio -6.6. It has cash and short-term investments of $291.0M.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ratio-6.6x
CashUS$291.02m
EquityUS$1.10b
Total liabilitiesUS$374.84m
Total assetsUS$1.48b

Recent financial health updates

We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn

Apr 01
We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn

Recent updates

Penumbra (NYSE:PEN) May Have Issues Allocating Its Capital

Oct 06
Penumbra (NYSE:PEN) May Have Issues Allocating Its Capital

Penumbra Grinding Through A Painful Growth Expectations Reset

Aug 20

What You Can Learn From Penumbra, Inc.'s (NYSE:PEN) P/S

Aug 01
What You Can Learn From Penumbra, Inc.'s (NYSE:PEN) P/S

Penumbra, Inc. (NYSE:PEN) Shares Could Be 23% Above Their Intrinsic Value Estimate

Jul 11
Penumbra, Inc. (NYSE:PEN) Shares Could Be 23% Above Their Intrinsic Value Estimate

Returns At Penumbra (NYSE:PEN) Appear To Be Weighed Down

Jun 19
Returns At Penumbra (NYSE:PEN) Appear To Be Weighed Down

Penumbra: Appeal Improves As Operating Leverage Continues

May 30

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Apr 12
Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Estimating The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Mar 21
Estimating The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Some Investors May Be Worried About Penumbra's (NYSE:PEN) Returns On Capital

Jan 23
Some Investors May Be Worried About Penumbra's (NYSE:PEN) Returns On Capital

A Look At The Fair Value Of Penumbra, Inc. (NYSE:PEN)

Nov 16
A Look At The Fair Value Of Penumbra, Inc. (NYSE:PEN)

Penumbra: Appeal Improves, Just Not Appealing Yet

Oct 16

Returns On Capital Signal Tricky Times Ahead For Penumbra (NYSE:PEN)

Oct 05
Returns On Capital Signal Tricky Times Ahead For Penumbra (NYSE:PEN)

Penumbra: Consolidation Does Nothing To Change Long-Term Thesis, Reiterate Buy

Sep 01

A Look At The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Aug 15
A Look At The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Penumbra (NYSE:PEN) Has Some Way To Go To Become A Multi-Bagger

Jun 28
Penumbra (NYSE:PEN) Has Some Way To Go To Become A Multi-Bagger

Penumbra: Future Upside Drivers In Fundamental, Sentimental And Valuation Factors

Jun 22

Getting In Cheap On Penumbra, Inc. (NYSE:PEN) Might Be Difficult

Jun 02
Getting In Cheap On Penumbra, Inc. (NYSE:PEN) Might Be Difficult

We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn

Apr 01
We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn

Penumbra Non-GAAP EPS of $0.16 beats by $0.01, revenue of $221.22M beats by $4.19M

Feb 23

Penumbra Riding Higher On Upcoming Launches And Rerating

Jan 12

Penumbra: Today's Best Medical Equipment Nearby Cap-Gain Buy

Nov 03

Penumbra cut to Neutral at Citi on macro concerns

Oct 05

Penumbra, Asahi team up to bring blood clot removing device Indigo to Japan

Sep 22

Financial Position Analysis

Short Term Liabilities: PEN's short term assets ($891.8M) exceed its short term liabilities ($153.2M).

Long Term Liabilities: PEN's short term assets ($891.8M) exceed its long term liabilities ($221.7M).

Debt to Equity History and Analysis

Debt Level: PEN is debt free.

Reducing Debt: PEN had no debt 5 years ago.

Debt Coverage: PEN has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: PEN has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y